FDA Authorizes AI Platform for Breast Cancer Risk Prediction

(MedPage Today) -- The FDA granted de novo authorization to the first artificial intelligence (AI) program to support breast cancer risk prediction from screening mammograms.
The program, called Clairity Breast, analyzes mammograms for subtle...